L'OCCITANE(00973.HK)第三財季銷售淨額增長17.9%
格隆匯1月21日丨LOCCITANE(00973.HK)發佈公告,2020財年第三季度,集團的銷售淨額按報告匯率計算增長17.9%,按固定匯率計算增長15.2%。2020財年九個月,集團的銷售淨額按報告匯率計算增長20.2%,按固定匯率計算增長17.3%。
此外,按品牌劃分的增長,LOccitane en Provence於2020財年第三季度持續增長強勁,增長為6.3%,且增長率於年初至今進一步增加至6.0%;Lime Life銷售於2020財年第三季度進一步改善11.7%,於2020財年九個月錄得稍微正增長;而ELEMIS於2020財年九個月約增長20%(未經審核)。
於2020財年第三季度按地區劃分的增長,英國以98.4%增幅領先,其次為中國及美國,分別增長32.4%及22.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.